Juan Manuel Schvartzman and Columbia stem cell researcher Dieter Egli are investigating the stressors that embryos experience during the very early period of replication.
The Columbia-led Nature study identified PrecisionChain as a solution to access vital genetic and clinical data and advance precision medicine studies.
Study led by Melissa Beauchemin, PhD, highlights that inadequate translation and interpretation services in the U.S. contributes to lack of representation in cancer clinical trials.
Including BRCA1 testing at the time of obstetrical prenatal carrier screening could identify at-risk people at a time when cancer screening could save their life.
New proof-of-concept study in Nature Biotechnology shows that changing only a single letter in the DNA code of selected genes in T cells may lead to improved cell therapy.
Congratulations to our Trainee Associate Membership program awardees, including our predoctoral and postdoctoral pilot awards, travel awards and papers of the year!